Patents by Inventor Martin Luber

Martin Luber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9744314
    Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterised in that it exhibits a low effective flow rate of less than about 5 liters per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.
    Type: Grant
    Filed: August 27, 2014
    Date of Patent: August 29, 2017
    Assignee: PARI Pharma GMBH
    Inventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
  • Patent number: 9717867
    Abstract: In a first aspect, the invention relates to a method for operating an aerosol inhalation device (10), comprising the steps of transporting a certain amount of an aerosol to a desired location outside said device (10) and vibrating the transported aerosol when it has reached said desired location. In a second aspect, the invention relates to an aerosol inhalation device (10) comprising a pump (1) for flowing a certain amount of an aerosol to a desired location outside the device (10), a vibrator (2) for vibrating the transported aerosol in a vibration mode and a control configured to actuate the vibrator (2) for vibrating the flowed aerosol only when it has reached said desired location.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: August 1, 2017
    Assignees: PARI GmbH Spezialisten für effektive Inhalation, PARI Pharma GmbH
    Inventors: Martin Luber, Andreas Boehm, Uwe Schuschnig, Axel Krüner
  • Patent number: 9046092
    Abstract: The compressor includes two compression spaces (1, 5) separate from one another, one of which serves to generate the continuous pressure medium flow for the generation of a basic aerosol flow, whereas the other is used to generate the pressure variations. The shared compression device (4), for example a piston, is moved in a pendulum motion by a drive (7) so that a gas is conveyed through the first compression space and pressure variations are imposed upon a gas volume via the second compression space. The drive is disposed in a compression space, use advantageously being made of the space volume available that may if necessary be made use of by the compressor. In a preferred embodiment the drive (7) is located in the compression space (5) that is used to generate the pressure variations.
    Type: Grant
    Filed: March 15, 2007
    Date of Patent: June 2, 2015
    Assignee: PARI GmbH Spezialisten für effektive Inhalation
    Inventors: Andreas Boehm, Martin Luber
  • Publication number: 20140366872
    Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterised in that it exhibits a low effective flow rate of less than about 5 litres per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.
    Type: Application
    Filed: August 27, 2014
    Publication date: December 18, 2014
    Inventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
  • Patent number: 8852557
    Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterized in that it exhibits a low effective flow rate of less than about 5 liters per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: October 7, 2014
    Assignee: PARI Pharma GmbH
    Inventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
  • Publication number: 20140137858
    Abstract: To increase the efficacy of atomizer nozzles operating with compressed gas, an atomizer device for inhalation therapy appliances includes means for delivering a compressed gas, in particular compressed air; means for supplying a fluid that is to be atomized, in particular a therapeutic liquid; several compressed gas outlet openings from which a delivered compressed gas emerges; and several fluid outlet openings from which the fluid to be atomized emerges on account of the emerging compressed gas. The atomizer device includes at least three compressed gas outlet openings arranged in a row, and one of the compressed gas outlet openings is in each case assigned at least two fluid outlet openings which, together with the associated compressed gas outlet opening, form an atomizer nozzle.
    Type: Application
    Filed: January 27, 2014
    Publication date: May 22, 2014
    Applicant: PARI GmbH Spezialisten für effektive Inhalation
    Inventors: Andreas Boehm, Martin Luber, Sven Rosenbeiger
  • Patent number: 8671933
    Abstract: To increase the efficacy of atomizer nozzles operating with compressed gas, an atomizer device for inhalation therapy appliances includes means for delivering a compressed gas, in particular compressed air; means for supplying a fluid that is to be atomized, in particular a therapeutic liquid; several compressed gas outlet openings from which a delivered compressed gas emerges; and several fluid outlet openings from which the fluid to be atomized emerges on account of the emerging compressed gas. The atomizer device includes at least three compressed gas outlet openings arranged in a row, and one of the compressed gas outlet openings is in each case assigned at least two fluid outlet openings which, together with the associated compressed gas outlet opening, form an atomizer nozzle.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: March 18, 2014
    Assignee: PARI GmbH Spezialisten für effektive Inhalation
    Inventors: Andreas Boehm, Martin Luber, Sven Rosenbeiger
  • Patent number: 8347878
    Abstract: Aerosol therapy device comprising a nebuliser (10) for generating an aerosol and forming an aerosol flow, a first nosepiece (11) for introducing the aerosol flow into one of the two nostrils (12) of a user, a pressure fluctuation source for generating a pressure fluctuation (DS), a second nosepiece (14) for introducing the pressure fluctuation into the other of the two nostrils (15) of the user in order to superimpose the pressure fluctuation and the aerosol flow, and a sensor system comprising a first pressure sensor (19) for detecting the signal of the pressure fluctuation that arrives at the first nosepiece (11), and an evaluation means (18) that concludes the degree of closure of the velum of the user based on the signal.
    Type: Grant
    Filed: April 7, 2008
    Date of Patent: January 8, 2013
    Assignee: PARI GmbH Spezialisten für effektive Inhalation
    Inventors: Uwe Schuschnig, Martin Luber, Wolfgang Achtzehner
  • Patent number: 8342171
    Abstract: A breath-controlled inhalation therapy device includes an obturation mechanism, obturating a nozzle opening through which a pressurised gas, preferably pressurised air, is issued when the device is in operation. An actuation mechanism actuates the obturation mechanism only in the exhalation phases of the respiration cycle of a patient. The fluid to be atomised is therefore substantially atomised only in the inhalation phases.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: January 1, 2013
    Assignee: PARI GmbH Spezialisten für effektive Inhalation
    Inventors: Andreas Boehm, Martin Luber
  • Publication number: 20120125326
    Abstract: A breath-controlled inhalation therapy device includes an obturation mechanism, obturating a nozzle opening through which a pressurised gas, preferably pressurised air, is issued when the device is in operation. An actuation mechanism actuates the obturation mechanism only in the exhalation phases of the respiration cycle of a patient. The fluid to be atomised is therefore substantially atomised only in the inhalation phases.
    Type: Application
    Filed: January 25, 2012
    Publication date: May 24, 2012
    Applicant: PARI GmbH Spezialisten fuer effektive Inhalation
    Inventors: Andreas Boehm, Martin Luber
  • Publication number: 20120085344
    Abstract: In a first aspect, the invention relates to a method for operating an aerosol inhalation device (10), comprising the steps of transporting a certain amount of an aerosol to a desired location outside said device (10) and vibrating the transported aerosol when it has reached said desired location. In a second aspect, the invention relates to an aerosol inhalation device (10) comprising a pump (1) for flowing a certain amount of an aerosol to a desired location outside the device (10), a vibrator (2) for vibrating the transported aerosol in a vibration mode and a control configured to actuate the vibrator (2) for vibrating the flowed aerosol only when it has reached said desired location.
    Type: Application
    Filed: February 27, 2009
    Publication date: April 12, 2012
    Applicants: PARI Pharma GmbH, PARI GmbH Spezialisten fuer effektive Inhalation
    Inventors: Martin Luber, Andreas Boehm, Uwe Schusching, Axel Kruener
  • Patent number: 8113194
    Abstract: A breath-controlled inhalation therapy device includes an obturation mechanism, obturating a nozzle opening through which a pressurized gas, preferably pressurized air, is issued when the device is in operation. An actuation mechanism actuates the obturation mechanism only in the exhalation phases of the respiration cycle of a patient. The fluid to be atomized is therefore substantially atomized only in the inhalation phases.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: February 14, 2012
    Assignee: PARI GmbH Spezialisten für effektive Inhalation
    Inventors: Andreas Boehm, Martin Luber
  • Patent number: 8006698
    Abstract: The invention regards a therapeutic aerosol device in which a main aerosol flow, which is generated with the help of a compressed gas and is supplied to one of the nostrils of a user, is superimposed by pressure fluctuations. The superimposition of the pressure fluctuations occurs directly at one of the two nostrils of the user. A flow resistance is provided in the other nostril.
    Type: Grant
    Filed: January 8, 2007
    Date of Patent: August 30, 2011
    Assignee: PARI GmbH Spezialisten fuer effektive Inhalation
    Inventors: Andreas Boehm, Martin Luber, Sven Rosenbeiger
  • Patent number: 7980247
    Abstract: A therapeutic aerosol device in which an aerosol generated by a nebulising device is supplied through a nosepiece to a patient's nostril so that the main aerosol flow supplied is able to emerge from the other nostril. The main aerosol flow is superimposed by pressure fluctuations. In order to guarantee that, due to the pressure fluctuation, aerosol is transported to the paranasal sinuses, a low resistance device is provided in the other nostril.
    Type: Grant
    Filed: August 27, 2003
    Date of Patent: July 19, 2011
    Assignee: PARI GmbH Spezialisten fuer effektive Inhalation
    Inventors: Andreas Boehm, Christiane Horn, Martin Luber, Markus Mornhinweg, Titus Selzer, Johann Zimmermann
  • Publication number: 20100316576
    Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterised in that it exhibits a low effective flow rate of less than about 5 litres per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.
    Type: Application
    Filed: August 29, 2008
    Publication date: December 16, 2010
    Applicant: PARI PHARMA GMBH
    Inventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
  • Publication number: 20090301473
    Abstract: To increase the efficacy of atomizer nozzles operating with compressed gas, an atomizer device for inhalation therapy appliances includes means for delivering a compressed gas, in particular compressed air; means for supplying a fluid that is to be atomized, in particular a therapeutic liquid; several compressed gas outlet openings from which a delivered compressed gas emerges; and several fluid outlet openings from which the fluid to be atomized emerges on account of the emerging compressed gas. The atomizer device includes at least three compressed gas outlet openings arranged in a row, and one of the compressed gas outlet openings is in each case assigned at least two fluid outlet openings which, together with the associated compressed gas outlet opening, form an atomizer nozzle.
    Type: Application
    Filed: March 8, 2007
    Publication date: December 10, 2009
    Applicant: PARI GMBH SPEZIALISTEN FUER EFFEKTIVE INHALATION
    Inventors: Andreas Boehm, Martin Luber, Sven Rosenbeiger
  • Publication number: 20090217923
    Abstract: A breath-controlled inhalation therapy device includes an obturation mechanism, obturating a nozzle opening through which a pressurized gas, preferably pressurized air, is issued when the device is in operation. An actuation mechanism actuates the obturation mechanism only in the exhalation phases of the respiration cycle of a patient. The fluid to be atomized is therefore substantially atomized only in the inhalation phases.
    Type: Application
    Filed: May 15, 2006
    Publication date: September 3, 2009
    Applicant: PARI GmbH Spezialisten fuer effektive Inhalation
    Inventors: Andreas Boehm, Martin Luber
  • Publication number: 20080251068
    Abstract: Aerosol therapy device comprising a nebuliser (10) for generating an aerosol and forming an aerosol flow, a first nosepiece (11) for introducing the aerosol flow into one of the two nostrils (12) of a user, a pressure fluctuation source for generating a pressure fluctuation (DS), a second nosepiece (14) for introducing the pressure fluctuation into the other of the two nostrils (15) of the user in order to superimpose the pressure fluctuation and the aerosol flow, and a sensor system comprising a first pressure sensor (19) for detecting the signal of the pressure fluctuation that arrives at the first nosepiece (11), and an evaluation means (18) that concludes the degree of closure of the velum of the user based on the signal.
    Type: Application
    Filed: April 7, 2008
    Publication date: October 16, 2008
    Applicant: PARI GmbH Spezialisten fuer effektive Inhalation
    Inventors: Uwe Schuschnig, Martin Luber, Wolfgang Achtzehner
  • Publication number: 20070215150
    Abstract: The compressor comprises two compression spaces (1, 5) separate from one another, one of which serves to generate the continuous pressure medium flow for the generation of a basic aerosol flow, whereas the other is used to generate the pressure variations. The shared compression means (4), for example a piston, is moved in a pendulum motion by a drive (7) so that a gas is conveyed through the first compression space and pressure variations are imposed upon a gas volume via the second compression space. The drive is disposed in a compression space, use advantageously being made of the space volume available that may if necessary be made use of by the compressor. In a preferred embodiment the drive (7) is located in the compression space (5) that is used to generate the pressure variations.
    Type: Application
    Filed: March 15, 2007
    Publication date: September 20, 2007
    Applicant: Pari GmbH Spezialisten fur effektive Inhalation
    Inventors: Andreas Boehm, Martin Luber
  • Publication number: 20070181133
    Abstract: The invention regards a therapeutic aerosol device in which a main aerosol flow, which is generated with the help of a compressed gas and is supplied to one of the nostrils of a user, is superimposed by pressure fluctuations. The superimposition of the pressure fluctuations occurs directly at one of the two nostrils of the user. A flow resistance is provided in the other nostril.
    Type: Application
    Filed: January 8, 2007
    Publication date: August 9, 2007
    Applicant: Pari GmbH Spezialisten fuer effektive inhalation
    Inventors: Andreas Boehm, Martin Luber, Sven Rosenbeiger